Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
0.1230
-0.0070 (-5.38%)
Apr 2, 2026, 3:59 PM HKT
HKG:8329 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 199.36 | 283.42 | 372.21 | 290.1 | 227.14 |
Short-Term Investments | 10 | - | 10 | 60 | 84 |
Cash & Short-Term Investments | 209.36 | 283.42 | 382.21 | 350.1 | 311.14 |
Cash Growth | -26.13% | -25.85% | 9.17% | 12.52% | -25.19% |
Accounts Receivable | 242.04 | 267.78 | 271.6 | 269.8 | 224.6 |
Other Receivables | 18.16 | 28.39 | 18.83 | 7.3 | 6.7 |
Receivables | 260.21 | 296.16 | 290.43 | 277.1 | 231.29 |
Inventory | 158.97 | 206.19 | 205.42 | 203.02 | 157.95 |
Other Current Assets | 23.94 | 23.25 | 42.53 | 64.87 | 39.59 |
Total Current Assets | 652.47 | 809.03 | 920.58 | 895.09 | 739.98 |
Property, Plant & Equipment | 261.42 | 277.95 | 284.57 | 299.5 | 307.82 |
Long-Term Investments | 10 | 115 | 10 | 30 | 30 |
Goodwill | - | 63.42 | 63.42 | 96.52 | 96.52 |
Other Intangible Assets | 119.45 | 120.33 | 122.15 | 110.4 | 115.75 |
Long-Term Deferred Tax Assets | 3.13 | 2.45 | 3.58 | 5.46 | 6.73 |
Other Long-Term Assets | 10.09 | 9.92 | 11.34 | 11.25 | 10.77 |
Total Assets | 1,057 | 1,398 | 1,416 | 1,448 | 1,308 |
Accounts Payable | 143.12 | 144.11 | 150.02 | 118.94 | 98.28 |
Accrued Expenses | - | - | - | 54.08 | 33.57 |
Short-Term Debt | 64.06 | 94.42 | 82.11 | 83.11 | 101.14 |
Current Portion of Long-Term Debt | 4.21 | 3.78 | 3.31 | 1.92 | - |
Current Portion of Leases | 1.99 | 1.95 | 0.5 | 3.18 | 3.94 |
Current Income Taxes Payable | 4.7 | 1.06 | 3.7 | 13.05 | 6.58 |
Current Unearned Revenue | 13.31 | 16.84 | 16.03 | 43.98 | 17.39 |
Other Current Liabilities | 93.27 | 78.27 | 110.5 | 94.47 | 74.59 |
Total Current Liabilities | 324.66 | 340.42 | 366.18 | 412.72 | 335.49 |
Long-Term Debt | 2.73 | 3.51 | 2.43 | 2.91 | - |
Long-Term Leases | - | 1.77 | 1.34 | 1.57 | 0.62 |
Long-Term Unearned Revenue | 0.59 | 0.59 | 0.59 | 0.59 | 0.94 |
Long-Term Deferred Tax Liabilities | 24.57 | 25.69 | 28.93 | 25.13 | 26.12 |
Total Liabilities | 352.55 | 371.99 | 399.46 | 442.93 | 363.17 |
Common Stock | 167.8 | 167.8 | 167.8 | 167.8 | 167.8 |
Additional Paid-In Capital | 554.84 | 554.84 | 554.84 | 554.84 | 554.84 |
Retained Earnings | 113.31 | 399.03 | 374.02 | 349.89 | 295.55 |
Comprehensive Income & Other | -188.49 | -188.49 | -188.49 | -188.49 | -188.49 |
Total Common Equity | 647.46 | 933.18 | 908.17 | 884.04 | 829.7 |
Minority Interest | 56.56 | 92.92 | 108.01 | 121.26 | 114.7 |
Shareholders' Equity | 704.01 | 1,026 | 1,016 | 1,005 | 944.4 |
Total Liabilities & Equity | 1,057 | 1,398 | 1,416 | 1,448 | 1,308 |
Total Debt | 72.99 | 105.43 | 89.69 | 92.69 | 105.69 |
Net Cash (Debt) | 136.37 | 177.99 | 292.52 | 257.41 | 205.45 |
Net Cash Growth | -23.39% | -39.15% | 13.64% | 25.29% | -49.38% |
Net Cash Per Share | 0.08 | 0.11 | 0.17 | 0.15 | 0.12 |
Filing Date Shares Outstanding | 1,678 | 1,678 | 1,678 | 1,678 | 1,678 |
Total Common Shares Outstanding | 1,678 | 1,678 | 1,678 | 1,678 | 1,678 |
Working Capital | 327.82 | 468.6 | 554.4 | 482.37 | 404.49 |
Book Value Per Share | 0.39 | 0.56 | 0.54 | 0.53 | 0.49 |
Tangible Book Value | 528 | 749.44 | 722.6 | 677.12 | 617.42 |
Tangible Book Value Per Share | 0.31 | 0.45 | 0.43 | 0.40 | 0.37 |
Buildings | - | 208.6 | 202.01 | 194.64 | 191.91 |
Machinery | - | 147.7 | 145.75 | 140.34 | 136.5 |
Construction In Progress | - | 0.33 | 0.3 | 2.86 | - |
Leasehold Improvements | - | 8.22 | 8.22 | 7.55 | 6.9 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.